George Perry

ORCID iD
orcid.org/0000-0002-6547-0172
  • Country
  • Show details Hide details
United States

Sources:
George Perry (2016-01-24)

  • Keywords
  • Show details Hide details
Alzheimer disease, Parkinson disease, oxidative stress, amyloid, cytoskeleton

Sources:
George Perry (2013-09-23)

  • Websites
  • Show details Hide details
Who is Famous

Sources:
George Perry (2016-04-02)

Researchgate

Sources:
George Perry (2016-01-23)

LinkedIn

Sources:
George Perry (2016-01-23)

Facebook

Sources:
George Perry (2016-01-23)

Authorea

Sources:
George Perry (2016-01-23)

Academia.edu

Sources:
George Perry (2016-01-23)

Twitter

Sources:
George Perry (2016-01-23)

Google Scholar

Sources:
George Perry (2016-01-23)

Publons

Sources:
George Perry (2016-01-23)

G+

Sources:
George Perry (2016-01-23)

UTSA

Sources:
George Perry (2016-01-23)

Slideshare

Sources:
George Perry (2016-01-23)

Notable Azorians

Sources:
George Perry (2016-01-23)

Naymoz

Sources:
George Perry (2016-01-23)

LiveDNA

Sources:
George Perry (2016-01-23)

Life Science Network

Sources:
George Perry (2016-01-23)

labroots

Sources:
George Perry (2016-01-23)

Expertisers Hub

Sources:
George Perry (2016-01-23)

Cestagi

Sources:
George Perry (2016-01-23)

Benchfly

Sources:
George Perry (2016-01-23)

Influuent

Sources:
George Perry (2016-01-23)

USERN

Sources:
George Perry (2016-01-23)

PAPS

Sources:
George Perry (2016-01-23)

Neurotree

Sources:
George Perry (2016-01-23)

Index Copernicus

Sources:
George Perry (2016-01-23)

Lifeboat Foundation

Sources:
George Perry (2016-01-23)

Faculty Row

Sources:
George Perry (2016-01-23)

Wikipedia

Sources:
George Perry (2016-01-23)

RTRN

Sources:
George Perry (2016-01-23)

Microsoft Academic Search

Sources:
George Perry (2016-01-23)

Frontiers

Sources:
George Perry (2016-01-23)

Quora

Sources:
George Perry (2016-04-28)

NCBI

Sources:
George Perry (2016-06-30)

American Law Society

Sources:
George Perry (2016-07-15)

Xing

Sources:
George Perry (2016-07-21)

Kudos

Sources:
George Perry (2016-07-25)

CiteULike

Sources:
George Perry (2016-08-01)

Mendeley

Sources:
George Perry (2016-08-01)

Science Open

Sources:
George Perry (2016-08-01)

  • Email
  • Show details Hide details
george.perry@utsa.edu

Sources:
0000-0002-6547-0172 (2013-09-23)

perry2500@gmail.com

Sources:
George Perry (2013-09-23)

  • Other IDs
  • Show details Hide details
ResearcherID: A-8611-2009

Sources:
0000-0002-6547-0172 (2013-09-23)

ISNI: 0000000068699517

Sources:
ISNI2ORCID search and link (2014-05-19)

Scopus Author ID: 7201545646

Sources:
Scopus to ORCID (2014-05-23)

Loop profile: 4570

Sources:
Loop (2016-01-23)

Biography

Distinguished as one of the top Alzheimer’s disease researchers with over 1000 publications, one of the top 100 most-cited scientists in neuroscience and behavior. Perry has been cited over 66,000 times (H=129) and is recognized as an ISI highly cited researcher. Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer's Disease. He is a fellow of the American Association for the Advancement of Sciences, Microscopy Society of America, International Engineering and Technology Institute, Texas Academy of Sciences, Association of Biotechnology and Pharmacy (FABAP), Royal Society of Chemistry (FRSC, CChem), Royal Society of Medicine, Royal College of Pathologists (FRCPath), Royal Society for the encouragement of Arts, Manufacturers and Commerce (FRSA), Royal Society of Biology (FRSB, CBio, CSci)and the Linnean Society of London (FLS), Royal Microscopical Society (FRMS), past-president of the American Association of Neuropathologists and the Southwestern and Rocky Mountain Division of the American Association for the Advancement of Science, Foreign Correspondent Member of the Spanish Royal Academy of Sciences, Foreign Corresponding Member of the Academy of Sciences of Lisbon, Corresponding member of the Mexican Academy of Sciences, Doctorado Honoris Causa (Hon. D.)-Universidad Arturo Prat, Iquique, Chile, and member of the Iberoamerican Molecular Biology Organization. He won the Distinguished Professional Mentor award from the Society for the Advancement of Chicanos and Native Americans in Sciences, Senior Investigator Award-International College of Geriatric Psychoneuropharmacology, Martin Goland Award- Alamo Chapter Sigma Xi, UDAAN-Lifetime Achievement Award, Top Specialist in Alzheimer disease- Expertscape, Denham Harman Award-American Aging Association, Zenith Award and Temple Award-Alzheimer Association, Mensch Award-Alzheimer Research Forum, Top Specialist in Alzheimer Disease-Expertscape, Notaveis dos Azores, Scientist of the Year-Portuguese Tribune, Senior Fulbright Fellow and the Panama National Plaque of Honor for Excellence in Neuroscience. Perry's research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of metabolic abnormalities.
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}}
     ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No education added yet
  • : , ,

    {{group.getActive().startDate.year}}-{{group.getActive().startDate.month}} to present {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}} {{group.getActive().endDate.year}}-{{group.getActive().endDate.month}}-{{group.getActive().endDate.day}}
     ()
    Source: {{(group.getActive().sourceName == null || group.getActive().sourceName == '') ? group.getActive().source : group.getActive().sourceName}}
    Created:
No employment added yet
No Funding added yet
No publications added yet